US-based merchant bank Burrill & Company has made a second closing of its latest healthcare fund at $505m after corporations joined. The fundraising followed the $2.6bn raised by venture capital firm New Enterprise Associates earlier this year, with more than $700m targeted for life sciences. Although corporations are known to have joined Burrill’s fund as limited partners, $200m of the total came from Rusnano, a Russia state-backed investment group, according to news provider Fierce Biotech. Accountants PricewaterhouseCoopers and US trade body National Venture Capital Association said venture funding for biotech fell to $697m between April and June, down 42% in the second quarter compared with the same period a year ago. It was the worst quarter for venture funding in the sector since 2003.
Sectors
- News & Analysis
- Home
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Publications
- Podcast
- Deal Data
- Video
- Subscribe
- Newsletters
- Community & Events
Burrill bores into $505m fund
Aug 5, 2012 • Global Corporate Venturing
LEADERSHIP SOCIETY
Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.Featured Content
FUNDING ROUND DATA Which corporates are backing which startups? Search our corporate deal database.FUNDING ROUND DATA
Which corporates are backing which startups? Search our corporate deal database.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.